Veterinary Supplier in Dubai | UAE

Mastering Alpha-2 Agonists: Dechra’s Two-Part Veterinary Anaesthesia Webinar Series

Dr Paulo Steagall presenting Dechra’s Mastering Alpha-2 Agonists veterinary anaesthesia webinar series, 15 and 22 September 2026

Dechra’s Two-Part Veterinary Anaesthesia Webinar Series - 15 & 22 September 2026 | 07:00 CET & 9:00 AM Dubai time

Veterinary anaesthesia requires more than following a standard protocol. Patient factors, procedure requirements and the pharmacology of the medicines being used all influence decisions around sedation, anaesthesia, analgesia and recovery.

This September, Dechra is hosting Mastering Alpha-2 Agonists: Beyond Protocols to Precision Practice, a two-part webinar series designed to provide veterinary professionals with practical, clinically relevant insights into the use of alpha-2 agonists in everyday practice.

The sessions will be presented by Dr Paulo Steagall, Professor of Veterinary Anaesthesia and Analgesia, and will explore the science behind alpha-2 agonists and its application to real-world clinical decision-making. 

Two Sessions: From Pharmacology to Clinical Cases

The webinar series takes place across two sessions:

Part I – 15 September 2026
Optimising alpha-2 agonists in your practice: pharmacology, sedation and anaesthesia

The first session focuses on the pharmacology of alpha-2 agonists and their application in sedation and anaesthesia.

Part II – 22 September 2026
Optimising alpha-2 agonists in your practice: clinical case discussions

The second session moves into clinical case discussions, providing an opportunity to consider how the principles surrounding alpha-2 agonist use translate into everyday veterinary practice.

According to Dechra, the two-part programme will cover the science behind alpha-2 agonists while translating current evidence into practical clinical decision-making, including sedation practices and peri-operative pain management.

An Opportunity to Earn FECAVA A&A Certification

Veterinarians who attend at least one of the two webinar sessions will be entered into a draw to win one of three fully funded places on the FECAVA Anaesthesia & Analgesia (A&A) Certification.

This provides an additional opportunity for participating veterinary professionals to continue developing their knowledge in anaesthesia and analgesia beyond the webinar series.

Register for the Dechra Alpha-2 Agonists webinar series

From Education to Everyday Practice: The Dechra Dog & Cat Anaesthesia App

The September webinars also provide a useful opportunity to revisit another resource available to veterinary professionals: the Dechra Dog & Cat Anaesthesia App.

Developed in collaboration with specialist veterinary anaesthetists and approved by the Association of Veterinary Anaesthetists (AVA), the App provides suggested anaesthetic protocols for dogs and cats, together with guidance covering areas including pre-operative considerations, premedication, peri-operative analgesia, induction and maintenance, monitoring and recovery. 

The App also includes information on commonly used anaesthetic and analgesic molecules, as well as practical features including dose calculation support, custom protocols, saved favourite protocols and printable or emailable protocol summaries. It also incorporates the AVA Anaesthetic Safety Checklist. 

Veterinary professionals can read more about the App, its features and how to access it here:

Dechra Dog & Cat Anaesthesia App – Veterinary Anaesthesia Support UAE

Sedator® and Atipam®: Part of Dechra’s A&A Portfolio

Alongside its educational resources, Dechra's Anaesthesia & Analgesia portfolio includes Sedator® and Atipam®, providing veterinary professionals with options supporting sedation and its reversal in dogs and cats. 

  • Sedator® contains medetomidine hydrochloride 1 mg/mL and is an injectable solution for dogs and cats. Dechra describes medetomidine as being used for restraint, sedation and analgesia and as part of anaesthetic protocols. 
  • Atipam® contains atipamezole hydrochloride 5 mg/mL and is a selective alpha-2 antagonist used to reverse the sedative effects of medetomidine and dexmedetomidine in dogs and cats. 

Supporting Veterinary Anaesthesia in the UAE

The September webinar series forms part of Dechra's wider focus on providing veterinary professionals with education, clinical resources and medicines within anaesthesia and analgesia. For veterinary professionals in the UAE, The Veterinary Group (TVG) is the UAE distributor of Dechra veterinary products.

To learn more about Dechra's Anaesthesia & Analgesia range or product availability in the UAE, contact the TVG team at sales@thevet.group or +971 6 539 5443.

 

Loading...